UBS AM’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.33M Buy
78,201
+841
+1% +$30.2K ﹤0.01% 1817
2026
Q1
$2.48M Buy
77,360
+22,618
+41% +$832K ﹤0.01% 1938
2025
Q4
$2.1M Buy
54,742
+6,124
+13% +$134K ﹤0.01% 1865
2025
Q3
$668K Sell
48,618
-62,140
-56% -$729K ﹤0.01% 2114
2025
Q2
$1.43M Buy
110,758
+51,371
+87% +$534K ﹤0.01% 2286
2025
Q1
$668K Buy
59,387
+6,368
+12% +$83.6K ﹤0.01% 2435
2024
Q4
$695K Buy
53,019
+19,831
+60% +$509K ﹤0.01% 2483
2024
Q3
$1.33M Buy
+33,188
New +$1.21M ﹤0.01% 2246

Other funds holding PACS

UBS AM's PACS Position: Q2 2026 in Review

UBS AM increased its PACS Group (PACS) stake by 1.1% in Q2 2026, buying an estimated $30.2K and bringing the position to 78,201 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

UBS AM first reported a position in PACS in Q3 2024 and has held it in 8 quarters since. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • UBS AM held 78,201 shares of PACS Group worth $3.33M as of Q2 2026.
  • UBS AM bought 841 PACS Group shares in Q2 2026, an estimated $30.2K.
  • PACS Group made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1817 holding.
  • UBS AM first reported a position in PACS Group in Q3 2024 and has held it in 8 quarters since.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.